Shawn Olsson

Insider Reports History

Location
Del Mar, CA
Signature
/s/ Daniel R. Chevallard, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shawn Olsson:

Company Role Class Num Shares Value Price $ Report Date Ownership
LENZ Therapeutics, Inc. Chief Commercial Officer Common Stock 4,733 $124,794 $26.37 17 Nov 2025 Direct
LENZ Therapeutics, Inc. Chief Commercial Officer Stock Option (right to buy) 84,200 02 Jan 2026 Direct
LENZ Therapeutics, Inc. Chief Commercial Officer Restricted Stock Unit 14,000 02 Jan 2026 Direct

Insider Reports Filed by Shawn Olsson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LENZ LENZ Therapeutics, Inc. 02 Jan 2026 2 $0 4 Chief Commercial Officer 06 Jan 2026, 16:22
LENZ LENZ Therapeutics, Inc. 17 Nov 2025 4 -$240,222 4 Chief Commercial Officer 19 Nov 2025, 19:02
LENZ LENZ Therapeutics, Inc. 09 Apr 2025 2 +$2,912 4 Chief Commercial Officer 09 Apr 2025, 19:20
LENZ LENZ Therapeutics, Inc. 09 Jan 2025 1 $0 4 Chief Commercial Officer 13 Jan 2025, 17:26
LENZ LENZ Therapeutics, Inc. 16 Dec 2024 2 +$6,933 4 Chief Commercial Officer 17 Dec 2024, 19:55
LENZ LENZ Therapeutics, Inc. 21 Mar 2024 4 $0 4 Chief Commercial Officer 25 Mar 2024, 20:34
LENZ LENZ Therapeutics, Inc. 21 Mar 2024 0 $0 3 Chief Commercial Officer 25 Mar 2024, 20:18